Submission of Matters to a Vote of Security Holders

On April 1, 2021, Mohawk Group Holdings, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). At the
Special Meeting, a total of 15,533,054 shares, or 52.62% of the Company’s common stock issued and outstanding as of March 11, 2021, the record date for the Special Meeting, were represented at the Special Meeting online or by proxy.

At the Special Meeting, the Company’s stockholders considered eight proposals, which are described in more detail in the Company’s definitive proxy
statement on Schedule 14A filed with the Securities and Exchange Commission on March 19, 2021.

Set forth below is a brief description of the matters
voted upon at the Special Meeting and the voting results with respect to such matters. In accordance with Nasdaq Listing Rules 5635(a) and 5635(d), the affirmative vote of the holders of a majority in voting power of the votes cast at the Special
Meeting by the holders entitled to vote thereon, excluding (1) the 1,387,759 shares of the Company’s common stock issued to Healing Solutions, LLC (the “Healing Solutions Shares”) on February 2, 2021 pursuant to the Asset
Purchase Agreement, dated February 2, 2021, by and among the Company, Truweo, LLC, Healing Solutions, LLC, Jason R. Hope and, for purposes of certain sections thereof, Super Transcontinental Holdings, LLC, and (2) the 980,000 shares of the
Company’s common stock issued to High Trail Investments SA, LLC on February 9, 2021 pursuant to the exercise of the Warrant to Purchase Common Stock, dated December 1, 2020 (the “High Trail Shares” and, together with the
Healing Solutions Shares, the “Excluded Shares”), was required for approval of each of Proposal Nos. 1 through 6. Accordingly, the voting results for Proposal Nos. 1 through 6 below exclude the Excluded Shares.

Proposal No.

 1:

To approve, as required by and in accordance with Nasdaq Listing Rules 5635(a) and 5635(d), the issuance of shares
of the Company’s common stock pursuant to the Senior Secured Note Due 2022.

For

Against

Abstain

13,131,858

20,118

13,319

Proposal No.

 2:

To approve, as required by and in accordance with Nasdaq Listing Rules 5635(a) and
5635(d), the issuance of shares of the Company’s common stock pursuant to the Senior Secured Note Due 2023.

For

Against

Abstain

13,131,907

20,325

13,063

Proposal No.

 3:

To approve, as required by and in accordance with Nasdaq Listing Rules 5635(a) and
5635(d), the issuance of up to 469,931 shares of the Company’s common stock upon exercise of the Warrant to Purchase Common Stock, dated February 2, 2021.

For

Against

Abstain

13,131,645

20,486

13,164

Proposal No.

 4:

To approve, as required by and in accordance with Nasdaq Listing Rules 5635(a) and
5635(d), the issuance of up to 1,016,912 shares of the Company’s common stock pursuant to the Asset Purchase Agreement, dated February 2, 2021, by and among the Company, Truweo, LLC, Healing Solutions, LLC, Jason R. Hope and, for purposes
of certain sections thereof, Super Transcontinental Holdings, LLC, including pursuant to certain consulting agreements entered into in connection therewith.

For

Against

Abstain

13,133,443

18,560

13,292

Proposal No.

 5:

To approve, as required by and in accordance with Nasdaq Listing Rules 5635(a) and
5635(d), the issuance of up to 750,000 shares of the Company’s common stock upon exercise of the Warrant to Purchase Common Stock, dated February 9, 2021.

For

Against

Abstain

13,131,596

20,430

13,269

Proposal No.

 6:

To approve, as required by and in accordance with Nasdaq Listing
Rules 5635(a) and 5635(d), the issuance of shares of the Company’s common stock pursuant to a senior secured note and upon exercise of a warrant to purchase common stock that may be issued in connection with a refinancing of the Senior Secured
Note Due 2022 and the Senior Secured Note Due 2023.

For

Against

Abstain

13,128,681

24,170

12,444

Proposal No.

 7:

To approve the issuance of up to $100.0 million of securities in one or more

non-public

offerings where the maximum discount at which securities will be offered will be equivalent to a discount of up to 20% below the market price of the Company’s common stock in accordance with Nasdaq
Listing Rules 5635(b) and 5635(d).

For

Against

Abstain

15,026,382

496,734

9,938

Proposal No.

 8:

To approve the adjournment of the Special Meeting, if necessary, to solicit
additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve the other proposals.

For

Against

Abstain

15,481,080

27,185

24,789

Although Proposal 8 was approved, the adjournment of the Special Meeting was not necessary because the Company’s
stockholders approved Proposal Nos.

1-7.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

MOHAWK GROUP HOLDINGS, INC.

Date: April 2, 2021

By:

/s/ Yaniv Sarig

Name:  Yaniv Sarig

Title:

    President and Chief Executive Officer

makes a similar move, sign up!

Other recent filings from the company include the following:

Mohawk Group Holdings: Aterian Reports First Quarter 2022 Results - May 9, 2022